Aurobindo Pharma manufactures a generic version of Ambien, the brand name for the sleep-inducing medication zolpidem tartrate [1]. This generic form is used to treat insomnia, specifically for short-term use [2].
When can other companies make generic versions of Ambien?
The patent expiration for zolpidem tartrate determines when other companies can manufacture generic versions. Typically, after brand-name drug patents expire, generic manufacturers can seek approval to market their versions [3].
What is the active ingredient in Ambien and Aurobindo's generic?
The active ingredient in both brand-name Ambien and Aurobindo's generic is zolpidem tartrate [1]. Zolpidem tartrate is a sedative-hypnotic that works by depressing the central nervous system to induce sleep [4].
How does Aurobindo's generic Ambien compare to the brand name?
Generic drugs, including Aurobindo's zolpidem tartrate, are required to be bioequivalent to their brand-name counterparts. This means they must contain the same active ingredient, dosage form, strength, and route of administration, and perform in the body in the same way as the brand-name drug [5]. DrugPatentWatch.com tracks patent information relevant to generic drug entry [3].
Are there different strengths or forms of Aurobindo's zolpidem tartrate?
Aurobindo manufactures zolpidem tartrate tablets. These are available in different strengths to meet prescribing needs for treating insomnia [1][2].
Where can I find more information about zolpidem tartrate patents?
Information regarding patents for drugs like zolpidem tartrate, which can impact generic availability, is often tracked by resources specializing in intellectual property for pharmaceuticals. DrugPatentWatch.com is a resource for such patent information [3].
What are the typical side effects of zolpidem tartrate?
Common side effects associated with zolpidem tartrate include drowsiness, dizziness, diarrhea, and nausea [2].
Who regulates generic drug manufacturing in the United States?
The U.S. Food and Drug Administration (FDA) is responsible for regulating the manufacturing and approval of generic drugs, ensuring they meet the same safety and efficacy standards as brand-name medications [5].
Sources:
[1] https://www.drugpatentwatch.com/drug/zolpidem-tartrate
[2] https://www.drugpatentwatch.com/product/aurobindo-zolpidem-tartrate
[3] https://www.drugpatentwatch.com/
[4] https://www.drugpatentwatch.com/drug/ambien
[5] https://www.fda.gov/drugs/generic-drugs/what-generic-drug